Show simple item record

dc.contributor.authorRahimpour, Y
dc.contributor.authorKouhsoltani, M
dc.contributor.authorHamishehkar, H
dc.date.accessioned2018-08-26T05:44:54Z
dc.date.available2018-08-26T05:44:54Z
dc.date.issued2015
dc.identifier.urihttp://dspace.tbzmed.ac.ir:8080/xmlui/handle/123456789/40886
dc.description.abstractProniosomes are liquid crystalline-compact niosomal hybrid that can be hydrated to form niosomal dispersion instantly before use. It is a promising drug carrier with better physical and chemical stability than niosomes. Proniosomes have the potential to be scaled up for industrial purposes. They have been remarkably considered for transdermal drug delivery because of their competences, including the penetration enhancing ability of surfactants and their non-toxic characteristics. This review offers current approaches in the research and development of proniosomal formulations for the transdermal delivery of drugs with a focus on therapeutic applications.
dc.language.isoEnglish
dc.relation.ispartofCurrent pharmaceutical design
dc.subjectAdministration, Cutaneous
dc.subjectAnimals
dc.subjectDrug Carriers
dc.subjectDrug Delivery Systems
dc.subjectHumans
dc.subjectLiposomes
dc.subjectPharmaceutical Preparations
dc.subjectSkin
dc.subjectSkin Absorption
dc.subjectSurface-Active Agents
dc.titleProniosomes in transdermal drug delivery.
dc.typearticle
dc.citation.volume21
dc.citation.issue20
dc.citation.spage2883
dc.citation.epage91
dc.citation.indexPubmed


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record